30
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2551 |
Etravirine
TMC125,依曲韦林,R165335 |
HIV Protease; Reverse Transcriptase | Microbiology/Virology; Proteases/Proteasome |
Etravirine (R165335) 是一种非核苷逆转录酶抑制剂,具有抗 HIV 的作用。 | |||
T70471 | Cgs 26303 | ||
Cgs 26303 is a potent non-peptidic inhibitor of neutral endopeptidase capable of protecting atrial natriuretic peptide from enzymatic degradation. | |||
T37970 |
12-epi Leukotriene B4
12-epi Leukotriene B4 |
||
Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes. The products of enzymatic origin, via Leukotriene A4 (LTA4) hydrolase, are stereospecifically 12(R). Non-enzymatic hydrolysis products are 50:50 mixtures at C-12, but are almost exclusively trans at C-6. Thus, the non-enzymatic hydrolysis product of LTA4 is 6-trans-12-epi LTB4. 12-epi LTB4 is an isomer which would not be expected to occur in either non-enzymatic hydrolysis products, or in the enzymatic pr... | |||
T35510 |
(±)15-HEDE
|
||
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. There are no reports in the literature of biological activity associated with (±)15-HEDE. | |||
T37653 |
5(S),6(S)-DiHETE
|
||
5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. | |||
T35466 |
(±)18-HEPE
|
||
(±)18-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 18(S)-HEPE and 18(R)-HEPE. Specific biological activity attributed to (±)18-HEPE has not been documented. | |||
T36609 |
(±)9-HEPE
|
||
(±)9-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 9(S)-HEPE and 9(R)-HEPE. The biological activity of (±)9-HEPE has not been clearly documented. | |||
T35511 |
(±)15-HEPE
|
||
(±)15-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 15(S)-HEPE and 15(R)-HEPE. Specific biological activity attributed to (±)15-HEPE has not been documented. | |||
T37642 |
Pravastatin lactone
|
||
Pravastatin lactone is a metabolite of pravastatin , a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that is a ring-hydroxylated metabolite of mevastatin . Pravastatin lactone is formed when pravastatin undergoes acid-catalyzed non-enzymatic lactonization in the stomach following oral administration. | |||
T36611 |
(±)13-HODE
|
||
(±)13-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid. It is the principle hydroxylated fatty acid in human psoriatic skin scales, with a mean concentration of 17 ng/mg.[1] | |||
T10165 |
5-A-RU
5-Amino-6-(D-ribitylamino)uracil |
Others | Others |
5-A-RU (5-Amino-6-(D-ribitylamino)uracil), a precursor of bacterial Riboflavin, is a mucosal-associated invariant T (MAIT) cells activator. 5-A-RU forms potent MAIT-activating antigens via non-enzymatic reactions with small molecules that are derived from | |||
T36543 |
Prostaglandin B2
PGB2 |
||
Prostaglandin B2 (PGB2) is a non-enzymatic dehydration product resulting from the treatment of PGE2 or PGA2 with strong base. It has weak agonist activity on TP receptors and can increase pulmonary blood pressure in the rabbit at relatively high doses (5 ug/kg). [1] | |||
T37925 |
7-Biopterin
|
||
7-Biopterin is a 7-substituted pterin.1It is formed by non-enzymatic rearrangement of 4a-hydroxy-tetrahydropterin in the absence of pterin-4a-carbinolamine dehydratase (PCD)in vitroand levels are elevated in the urine of hyperphenylalaninemia patients carrying heterozygous mutations in the PCBD gene encoding PCD.1,2 | |||
T36604 |
(±)5-HETE
|
||
(±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM.[1] | |||
T35462 |
(±)11-HETE
|
||
(±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid . The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quantified as an index of lipid peroxidation using GC/MS. | |||
T35507 |
12-HETE
|
||
(±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)12-HETE is similar to that of its constituent enantiomers . It aggregates neutrophils with an EC50 value of 40 nM.[1] Reference:[1]. O'Flaherty, J.T., Thomas, M.J., Lees, C.J., et al. Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. American Journal of Pathology 104, 55-62 (1981). | |||
T36558 |
(±)9-HETE
|
||
(±)9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quantified as an index of lipid peroxidation using GC/MS. | |||
T36559 |
(±)9-HODE
|
||
(±)9-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid. Approximately equal proportions of both isomers are found in mitochondrial and plasma membranes of rabbit reticulocytes. [1][2] Oxidized LDL contains significant amounts of esterified 9- and 13-HpODEs and HODEs. [3][4] | |||
T63899 | RECQL5-IN-1 | ||
RECQL5-IN-1 是口服具有活力的 RECQL5 抑制剂 (靶向酶域和非酶域),是有效的 RECQL5 解旋酶活性抑制剂 (IC50为 46.3 nM)。RECQL5-IN-1 能够抑制 RECQL5-WT 细胞 (IC50: 4.8 μM) 和 RECQL5-KO2 细胞 (IC50: 19.6 μM)。RECQL5-IN-1 能够用于研究乳腺癌。 | |||
T36608 |
(±)8-HEPE
|
||
(±)8-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 8(S)-HEPE and 8(R)-HEPE. The ability of (±)8-HEPE to induce hatching of E. modestus and B. balanoides eggs is probably due to the presence of the 8(R) isomer within the racemic mixture.[1][2] Reference:[1]. Shing, T.K.M., Gibson, K.H., Wiley, J.R., et al. First total synthesis of a barnacle hatching factor 8(R)-hydroxy-eicosa-5(Z),9(E),11(Z)-pentaenoic acid. Tetrahedron Letters 35, 1067-1070 (1994).[2]. Hill, E... | |||
T35990 |
ent-8-iso-15(S)-Prostaglandin F2α
ent-8-iso-15(S)-Prostaglandin F2α |
||
Isoprostanes are produced by the non-enzymatic, free radical peroxidation of phospholipid-esterified arachidonic acid. They have been used as biomarkers of oxidative stress, but they also have been found to have potent biological activity. ent-8-iso-15(S)-Prostaglandin F2α (ent-8-iso-15(S)-PGF2α) is a potent vasoconstrictor of porcine retinal and brain microvessels with EC50 values of 15 and 24 nM, respectively. This isoprostane is about ten-fold more potent than 8-iso-PGF2α in a whole blood pla... | |||
T35506 |
(±)12-HEPE
|
||
(±)12-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 12(S)-HEPE and 12(R)-HEPE. The biological activity of (±)12-HEPE is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet aggregation with the same potency as 12-HETE, exhibiting IC50 values of 24 and 25 µM, respectively. [1] These compounds are also equipotent as inhibitors of U46619-induced contraction of rat aorta (IC50s = 8.6-8.... | |||
T36603 |
(±)5-HEPE
|
||
(±)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE. The biological activity of (±)5-HEPE is likely mediated by one of the individual isomers, most commonly the 5(S) isomer in mammalian systems. EPA can be metabolized to 5-HEPE in human and bovine neutrophils, and human eosinophils, which is further metabolized to 5-oxoEPE and LTB5. The 5-series metabolites of EPA, namely 5-HEPE, 5-oxoEPE, and LTB5, have significantly decreased biological... | |||
T78071 |
3-Methylglutaconic acid
β-Methylglutaconic acid |
GABA Receptor | Membrane transporter/Ion channel; Neuroscience |
3-Methylglutaconic acid 是MGTA (3-甲基戊二酸尿症) 的主要积累代谢物,能够诱发脂质和蛋白质的氧化损伤,减弱大脑皮层上清液的非酶促抗氧化防御,导致氧化应激。此化合物适用于研究大脑损伤相关疾病。 | |||
T61031 | HIV-1 inhibitor-41 | ||
HIV-1 inhibitor-41 (Compound B23) 是口服有效的非核苷 HIV-1 逆转录酶抑制剂,其对突变型 E138K 菌株和 HIV-1 野生型的EC50值分别为 50 nM 和 20.8 nM。HIV-1 inhibitor-41 表现出低 hERG 抑制作用,没有明显 CYP 酶抑制活性,也没有急性毒性。 | |||
T11896 |
LV-320
|
Cysteine Protease | Proteases/Proteasome |
LV-320 是一种有效且非竞争性的ATG4B 抑制剂,其IC50值为 24.5 μM,Kd 值为 16 μM。 LV-320 抑制ATG4B 的酶促活性,阻断细胞自噬,并且稳定无毒,在体内具有活性。 | |||
T75509 | Pulcherriminic acid | ||
Pulcherriminic acid 是环状二肽抗菌剂,对Fe3+有高亲和力,主要在芽孢杆菌和酵母中发现。该化合物通过非酶促反应与铁离子螯合,生成细胞外红色素pulcherrimin,通过竞争铁营养达到抗菌效果。Pulcherriminic acid 在食品、农业和医疗等领域具有广泛应用潜力。 | |||
T35890 |
Pentosidine
|
||
Advanced glycation end products (AGEs) are compounds formed by non-enzymatic chemical reactions following the bonding of sugars to proteins or lipids during diabetes, uremia, aging, rheumatic arthritis, and other conditions. A receptor for the AGEs (RAGE) binds certain members of this class to initiate cell signaling.[1][2] Pentosidine is a well-characterized natural AGE that is often used as a biomarker for the production of all AGEs. While pentosidine can be measured in urine, the majority of ... | |||
T36167 |
8-iso-15-keto Prostaglandin F2β
8-iso-15-keto Prostaglandin F2β |
||
8-iso Prostaglandin F2β (8-iso PGF2β) is an isomer of PGF2α of non-enzymatic origin. It is one of 64 possible isomers of PGF2α which can be produced by free radical peroxidation of arachidonic acid. 8-iso PGF2β exhibits very weak contraction of human umbilical vein artery and does not promote aggregation of human whole blood. However, 8-iso PGF2β moderately contracts both the canine and porcine pulmonary vein, although the effect is much weaker than that exhibited by other isoprostanes such as 8... | |||
T83662 |
2,3-dinor-8-iso Prostaglandin F1α
2,3-dinor-8-iso PGF1α,2,3-dinor-iPF1α-III,2,3-dinor-5,6-dihydro-15-F2t-Isoprostane,2,3-dinor-5,6-dihydro-15-F2t-IsoP |
||
2,3-dinor-8-iso Prostaglandin F1α(2,3-dinor-8-iso PGF1α)是一种异前列腺素和花生四烯酸的活性代谢物,也是血小板聚集抑制剂8-iso PGF2α的产物。它通过花生四烯酸的非酶促自由基过氧化作用形成。2,3-dinor-8-iso PGF1α在孤立的猪视网膜和大脑微血管中引起血管收缩(EC50s分别为12.8和18.5 nM),但在31 µM的浓度下使用时不会引起孤立的大鼠主动脉环的收缩。在1 µM的浓度下使用时,它能增加孤立的猪大脑切片中的血栓素B2(TXB2)水平,这一效应可以通过血栓素A合成酶抑制剂CGS 12970、电压门控钙通道抑制剂SKF 96365或烟碱型乙酰胆碱受体(nAChR)拮抗剂α-conotoxin来逆转。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19161 |
7α-Hydroxycholesterol
|
Others | Others |
7α-Hydroxycholesterol 是一种由酶促氧化和非酶促氧化形成的胆固醇氧化物,可用作脂质过氧化的生物标志物。 | |||
T3415 |
Secoisolariciresinol diglucoside
亚麻木酚素,LGM2605 |
ROS | Immunology/Inflammation |
Secoisolariciresinol diglucoside (LGM2605) 在铁过载诱导的氧化还原炎症损伤的体外模型中具有细胞保护作用。 Secoisolariciresinol Diglucoside(25 mg/kg b.w.) 通过抑制 ROS 水平介导的酶和非酶抗氧化剂水平升高来防止肝脏受到过氧化损伤,从而发挥抗高血糖作用。 |